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Abstract We previously reported that tumor necrosis factor-K
(TNF) and lipopolysaccharide (LPS) stimulate DNA synthesis in
chick embryo cardiomyocytes (CM) via nitric oxide and
polyamine biosynthesis. Here we show an involvement of nuclear
factor-UB (NF-UB) in the induction of nitric oxide synthase
(NOS) and ornithine decarboxylase (ODC), the key enzyme in
polyamine biosynthesis. In addition NF-UB activation appears to
favor survival of CM by reducing caspase activation. TNF and
LPS also stimulate phosphorylation of extracellular signal-
regulated kinase (ERK), which is required for the changes in
ODC and caspase activity, but not for NOS induction or NF-UB
activation. In conclusion, these results indicate that NF-UB, in
cooperation with ERK, plays a pivotal role in the growth
stimulating effects of TNF and LPS, leading to the induction of
both ODC and NOS and to the reduction of caspase
activity. ß 2002 Federation of European Microbiological So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Tumor necrosis factor-K (TNF) and lipopolysaccharide
(LPS) share a common spectrum of cellular activities includ-
ing growth, di¡erentiation and apoptosis [1,2] and can evoke
in£ammation and cardiovascular responses [3,4]. The molec-
ular mechanisms responsible for the multiple biological activ-
ities of TNF and LPS are not completely clari¢ed, but these
are probably due to their ability to activate multiple signal
transduction pathways [5,6], including those involving extra-
cellular signal-regulated kinase (ERK) and other mitogen-ac-
tivated protein kinases (MAPKs), which play critical roles in
cell proliferation and survival [7]. TNF and LPS also activate
nuclear factor-UB (NF-UB), a factor that promotes transcrip-
tion of a large family of genes [8]. NF-UB is a member of Rel
family of proteins and is typically an heterodimer composed
of a p50 and p65 (Rel A). In quiescent cells NF-UB resides in
the cytosol in a latent form bound to an inhibitor protein
(I-UB). Stimulation of the cell with various cytokines, LPS or
oxidants, triggers a series of signalling events that ultimately
leads to the phosphorylation and the proteolytic degradation
of I-UB, and activation of NF-UB. The phosphorylation of
I-UB is elicited by an I-UB kinase, which can be activated by
MAPKs [9,10], while the proteolysis of I-UB is mediated by
the ubiquitin-proteasome pathway of protein degradation.
The degradation of I-UB triggers the translocation of NF-UB
from the cytoplasm to the nucleus where it regulates the ex-
pression of multiple genes. It has been reported that TNF
activation of NF-UB protects against apoptosis [11] and stim-
ulates the proliferation of some cell types [12,13], whereas
TNF-induced apoptosis involves the recruitment of the signal
transducer FADD to type I TNF receptor [14]. A few NF-UB
target genes that regulate apoptosis have been identi¢ed [15],
however little is known about the targets of NF-UB relevant
for its proliferative e¡ects.
Cardiomyocyte (CM) proliferation occurs during embry-
onic and neonatal development and, according to recent evi-
dence [16], even in the adult heart, particularly under certain
pathological conditions such as myocardial infarction. There-
fore it may be important to identify extracellular mediators
and intracellular pathways leading to DNA replication in
CM. Our previous report [17] indicates that in chick embryo
CM cultures, TNF and LPS exert a mitogenic e¡ect through a
pathway involving polyamine and nitric oxide (NO) biosyn-
theses. In the present study we report data supporting the
involvement of NF-UB in the induction of ornithine decarbox-
ylase (ODC), the key enzyme in polyamine biosynthesis [18],
and nitric oxide synthase (NOS). Simultaneously, NF-UB ac-
tivation appears to favor survival of CM by reducing caspase
activation, a critical event in the executive phase of apoptosis.
Activation of ERK may also be involved in these events.
2. Materials and methods
2.1. CM cultures
Preparation of monolayer cultures of spontaneously beating em-
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bryo CM from the hearts of 10 day-old chick embryos was carried out
as previously described [17]. This method resulted in preparations
containing s 95% CM, as assayed by immuno£uorescence staining
with antibodies against cardiac myosin heavy chain, which began to
beat spontaneously after 2 days in culture. Con£uent cultures were
then serum-starved for 20 h before treatment with the di¡erent drugs,
as described in the legends. Cell death was evaluated by trypan blue
exclusion, with the percentage of cell death being de¢ned as the per-
centage of cells that include the dye.
2.2. Enzymatic assays
The ODC and NOS activities were measured by estimation of the
release of 14CO2 from L-[1-14C]ornithine or monitoring L-[3H]citrulline
formation from L-[2,3-3H]arginine as previously described [19]. The
activity of caspase enzymes was measured by the cleavage of the
£uorogenic peptide substrate Ac-DEVD-AMC during a 15-min incu-
bation at 37‡C, as detailed elsewhere [20]. Since the DEVD sequence
represents a substrate for caspase-3 and other members of the caspase
family, this activity will be referred to as caspase activity. Data are
expressed as pmol/mg protein/min.
2.3. [3H]Thymidine incorporation
DNA synthesis was quanti¢ed by [3H]thymidine incorporation of
subcon£uent CM cultures. The cells, maintained for 20 h in serum-
free Dulbecco’s modi¢ed Eagle’s medium, were then treated with the
di¡erent drugs, and pulsed during the last 2 h with [3H]thymidine [17].
Data are expressed as % of the radioactivity measured under basal
conditions.
2.4. Western blot analysis and electrophoretic mobility shift assay
(EMSA)
Western blot analysis of phosphorylated ERK was performed by
using phosphospeci¢c antibody as described elsewhere [21]. DNA
binding activity of NF-UB was assayed in nuclear extracts as previ-
ously described [22].
2.5. Statistical analyses
Values are given as means þ S.D. All experiments were performed
with at least three independent CM cultures.
3. Results and discussion
3.1. NF-UB mediates induction of ODC and NOS and reduction
of caspase activity in TNF and LPS treated CMs
We have ¢rst ascertained whether NF-UB may be activated
in TNF and LPS treated CM. DNA binding activity of the
transcription factor NF-UB was evaluated by EMSA. Fig. 1A
shows that serum-starved CM has a low basal level of NF-UB
activity, which increases after 30 and 60 min of TNF and LPS
treatment. When the cells were pre-incubated with n-acetylleu-
cilleucinal (LLL), an inhibitor of the ubiquitine-26S protea-
some degrading I-UB [23], a complete prevention of TNF and
LPS mediated NF-UB activation was observed. The gel shift
bands were speci¢c NF-UB^DNA^protein complexes, because
the addition of excess unlabelled NF-UB oligonucleotide to
nuclear extract speci¢cally abolished the NF-UB signal.
We have previously shown that TNF and LPS exert a mi-
togenic e¡ect in chick embryo CM through a pathway that
involves an increase in polyamine and NO biosyntheses [17].
In fact ODC and NOS activities were strongly induced after
treatment of CM with TNF and LPS, as also reported in Fig.
1B. The increase of NOS activity may result from induction of
iNOS, as shown in other experimental systems [24]. It has
been described that the promoter region of the iNOS gene
contains the consensus sequence for the binding of NF-UB,
which is known to control iNOS expression in a variety of cell
types [25]. Sequences in the ODC gene that show similarities
to binding sites for NF-UB, have been noted [26], however we
are not aware of published reports showing the actual involve-
ment of this transcription factor in the regulation of ODC
expression.
In order to determine whether TNF- and LPS-induced
ODC and NOS activities in CM were mediated by NF-UB
activation, experiments were performed with the aid of three
structurally di¡erent inhibitors of NF-UB, which act by di¡er-
ent mechanisms: LLL, already mentioned above, pyrrolidine
Fig. 1. NF-UB is activated in con£uent chick embryo CM treated with TNF and LPS and is required for ODC and NOS induction. A: Serum-
starved CM were treated with 500 U/ml TNF and 10 Wg/ml LPS for 30 and 60 min. 5 WM LLL was added 2 h before TNF and LPS. Cell ex-
tracts were analyzed for DNA binding activity of NF-UB by EMSA. B: Serum-starved CM were treated with 500 U/ml TNF and 10 Wg/ml
LPS for 4 h (ODC) or for 8 h (NOS). 10 WM PDTC, 5 WM LLL or 10 WM Bay 11-7082 were added 2 h before TNF and LPS. The results are
expressed as relative activity with respect to the activities of control cells, taken as 1.0. Control ODC activity was 0.30 þ 0.1 pmol/mg protein/
min. Control NOS activity was 2.4 þ 0.3 pmol/mg protein/min.
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dithiocarbamate (PDTC), which blocks NF-UB activity by an
antioxidant mechanism [27] and Bay 11-7082, a speci¢c IUBa-
kinase inhibitor [28]. Fig. 1B indicates that pre-incubation of
the cells with each of the di¡erent inhibitors prevents the
induction of ODC and NOS activities by TNF and LPS,
suggesting that NF-UB activation is involved in the pathway
by which TNF and LPS lead to ODC and NOS induc-
tion.
On the other hand substantial evidence indicates that acti-
vation of cell proliferation sensitizes cells to apoptosis, which
may proceed following cell damage or even spontaneously,
unless the mitogenic stimuli provide survival signals [29]. It
Fig. 2. TNF and LPS reduce cell death and caspase activity in con£uent chick embryo CM. A, B: Serum-starved CM were treated for 24 h
(A) or for 6 h (B) with 500 U/ml TNF and 10 Wg/ml LPS in the presence or absence of 1 WM STS. C: Serum-starved CM were treated with
500 U/ml TNF and 10 Wg/ml LPS. D: Serum-starved CM, pre-treated for 20 h with 4 mM DFMO, for 1 h with 100 WM L-NMMA or for 2 h
with 10 WM PDTC, 5 WM LLL or 10 WM Bay 11-7082 were then incubated with 500 U/ml TNF and 10 Wg/ml LPS for 6 h.
Fig. 3. Activation of ERK in con£uent chick embryo CM treated with TNF and LPS and e¡ect of PD98059 on ODC and NOS induction and
caspase changes. A: Serum-starved CM were treated with 500 U/ml TNF and 10 Wg/ml LPS or 10% serum. 5 WM LLL was added 2 h before
TNF and LPS. Cell extracts were analyzed by Western blot by using speci¢c antibodies. B: Serum-starved CM were treated for 4 h (ODC), 8 h
(NOS) or 6 h (caspase) with 500 U/ml TNF and 10 Wg/ml LPS. 50 WM PD98059 was added 1 h before TNF and LPS.
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is also known that TNF can favor either cell death or survival
in various cell types, including CM, depending on the devel-
opmental stage, association with other stimuli and other ex-
perimental conditions [1,3,6]. Therefore we have investigated
whether, in our model of chick embryo CM, TNF and LPS
a¡ect cell viability. Fig. 2A reports how the treatment with
TNF and LPS for 24 h caused a reduction of the fraction of
dead cells, both under basal conditions (by 43%) and after
addition of staurosporine (STS), a widely used and potent
inducer of apoptosis. Furthermore, the pro-survival e¡ect of
TNF and LPS was accompanied by corresponding changes in
the activity of caspases, proteolytic enzymes that are known
to play a central role in apoptosis. In fact Fig. 2B shows that
TNF and LPS treatment reduced both basal and STS-induced
caspase activity. The time-course of caspase activity in chick
embryo CM treated only with TNF and LPS is depicted in
Fig. 2C, showing a progressive reduction up to 8 h of incu-
bation (Fig. 2C). This e¡ect was completely prevented when
the cells were pre-incubated with the NF-UB inhibitors LLL,
PDTC or Bay 11-7082 (Fig. 2D), indicating that even caspase
inhibition by TNF and LPS is an NF-UB mediated event. It
has been reported that in some cell systems NO and poly-
amines may play protective roles in apoptosis [30,31]. How-
ever, Fig. 2D shows that the inhibition of caspase activity by
TNF and LPS is a polyamine and NO independent phenom-
enon. In fact the pre-treatment of CM cultures with K-di£uo-
romethylornithine (DFMO), a speci¢c ODC inhibitor, or with
NG-monomethylarginine (L-NMMA), a competitive inhibitor
of NOS, was without e¡ect on the inhibition of caspase ac-
tivity by TNF and LPS.
3.2. ERK activation is required for the induction of ODC and
the reduction of caspase activity
Another important signaling pathway that may be activated
by TNF and/or LPS, is that involving ERK, which is consid-
ered to play an essential role in mitogenesis and, in some cell
types, even in cell survival [7]. Therefore, the activation/phos-
phorylation of ERK was investigated in our experimental sys-
tem. By using speci¢c antibodies against total or phosphory-
lated ERK, a single immunoreactive band was detected (Fig.
3A). The total content of ERK did not vary following 3 h of
TNF and LPS treatment; however, the active, phosphorylated
ERK, very low in quiescent CM, increased markedly within
30 min of TNF and LPS treatment, although not as much as
after serum stimulation, and remained high for up to 3 h.
Given the importance of ODC and NOS for the mitogenic
action of TNF and LPS treatment, we investigated the e¡ect
of PD98059, a speci¢c MEK inhibitor widely used to dissect
the ERK pathway [32], on the induction of ODC and NOS
(Fig. 3B). PD98059, which prevented TNF- and LPS-induced
ERK activation (not shown), proved to be a potent inhibitor
of ODC induction, but did not in£uence NOS induction. We
have previously shown that ERK activation is required for
ODC expression and induction in serum-stimulated leukemia
cells [21] and in ECV304 cells stimulated with some ligands of
G-protein coupled receptors [33]. In addition PD98059 re-
versed the TNF and LPS e¡ect on caspase activity in CM
(Fig. 3B), supporting a pro-survival e¡ect of ERK. In some
cell systems the anti-apoptotic action of ERK has been related
to its ability to a¡ect phosphorylation and expression of Bcl-2
family members [7], which in turn may control cytochrome c
release and thus caspase activation.
3.3. NF-UB and ERK cooperate to stimulate DNA synthesis
Fig. 4 shows that the treatment of CM with PD98059, LLL,
DFMO or L-NMMA, inhibited the stimulation of DNA syn-
thesis elicited by TNF and LPS. This indicates that activation
of ERK and NF-UB, as well as induction of ODC and NOS,
are all events required for the stimulation of DNA synthesis
by TNF and LPS. Since blockade of either ODC or NOS
pathway is su⁄cient to prevent the increase in DNA synthesis,
it is not surprising that PD98059 and LLL, which also inhibit
ODC and/or NOS induction, reproduce the same result.
It has been reported that in some experimental models
ERK stimulation leads to NF-UB activation [9,10]. However
treatment of CM with PD98059 was not able to prevent NF-
UB activation by TNF and LPS, as judged by gel shift assay
(not shown), indicating that under our experimental condi-
tions NF-UB is not placed downstream of ERK. This would
be in agreement with the ¢nding that NF-UB blockade pre-
vents the TNF- and LPS-induced changes in ODC, NOS and
caspase activities, whereas inhibition of the ERK pathway
prevents only the ODC and caspase modi¢cations. On the
other hand the increase of ERK phosphorylation was almost
completely abolished in the presence of LLL (Fig. 3B), where-
as it was not by Bay 11-7082 (not shown). These latter data
suggest that the proteasome, but not NF-UB may be involved
in the control of ERK phosphorylation.
In conclusion the present results are consistent with a pic-
ture where NF-UB plays a pivotal role in the mitogenic e¡ect
of TNF and LPS, leading to the induction of both ODC and
NOS enzymes. We have previously shown [17] that in turn a
rise in cGMP content mediates the e¡ects of polyamines and
NO accumulation. In addition TNF and LPS provoke ERK
stimulation that is also required for ODC induction and DNA
synthesis. Simultaneously, NF-UB and ERK cooperate even to
reduce caspase activity, thus favoring cell survival. Finally,
according to the experiments with PD98059 and Bay 11-
7082, NF-UB is not located downstream of ERK in this sys-
tem, but NF-UB and ERK may be placed on separate path-
ways that converge to favor proliferation and survival of CM.
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